Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nimodipine 30mg/5ml oral suspension
0206020M0AAACAC
|
Nimodipine | Nimodipine | Cardiovascular System | No data available |
|
Nimodrel XL 30mg tablets
0206020R0BUACAN
|
Nimodrel | Nifedipine | Cardiovascular System | No data available |
|
Nimodrel XL 60mg tablets
0206020R0BUADAP
|
Nimodrel | Nifedipine | Cardiovascular System | No data available |
|
Nimotop 0.02% solution for infusion 50ml vials
0206020M0BBAAAA
|
Nimotop | Nimodipine | Cardiovascular System | No data available |
|
Nimotop 30mg tablets
0206020M0BBABAB
|
Nimotop | Nimodipine | Cardiovascular System | No data available |
|
Nindaxa 2.5 tablets
0202010P0BDAAAA
|
Nindaxa 2.5 | Indapamide | Cardiovascular System | No data available |
|
Nisoldipine 10mg modified-release tablets
0206020W0AAAAAA
|
Nisoldipine | Nisoldipine | Cardiovascular System | No data available |
|
Nisoldipine 20mg modified-release tablets
0206020W0AAABAB
|
Nisoldipine | Nisoldipine | Cardiovascular System | No data available |
|
Nisoldipine 30mg modified-release tablets
0206020W0AAACAC
|
Nisoldipine | Nisoldipine | Cardiovascular System | No data available |
|
Nitro-Dur 0.2mg/hour transdermal patches
0206010F0BSABBH
|
Nitro-Dur | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Nitro-Dur 0.4mg/hour transdermal patches
0206010F0BSACBI
|
Nitro-Dur | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Nitro-Dur 0.6mg/hour transdermal patches
0206010F0BSADBJ
|
Nitro-Dur | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Nitrocine 10mg/10ml solution for infusion ampoules
0206010F0BDAACL
|
Nitrocine | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Nitrocine 50mg/50ml solution for infusion vials
0206010F0BDABAV
|
Nitrocine | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Nitronal 50mg/50ml solution for infusion vials
0206010F0BGABAV
|
Nitronal | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Nitronal 5mg/5ml solution for infusion ampoules
0206010F0BGAAAU
|
Nitronal | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Nonacog alfa 1,000unit inf vials
0211000J0AAADAD
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 2,000unit inf vials
0211000J0AAAGAG
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 250unit inf vials
0211000J0AAACAC
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 3,000unit inf vials
0211000J0AAAHAH
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 500unit inf vials
0211000J0AAABAB
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Noradrenaline (base) 2mg/2ml solution for infusion ampoules
0207020R0AAAEAE
|
Noradren acid tartrate | Noradrenaline acid tartrate | Cardiovascular System | No data available |
|
Noradrenaline (base) 4mg/4ml solution for infusion ampoules
0207020R0AAAFAF
|
Noradren acid tartrate | Noradrenaline acid tartrate | Cardiovascular System | No data available |
|
NovoSeven 120,000unit inj vials
0211000Z0BBABAB
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 1mg (50,000units) inj pfs
0211000Z0BBAHAH
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.